PUMA BIOTECHNOLOGY INC (PBYI) Stock Balance Sheet
USA - NASDAQ:PBYI - US74587V1070 - Common Stock
4.95 USD
-0.04 (-0.8%)
4.95 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 54.66M | 69.22M | 84.58M | 76.20M | 63.10M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 41.36M | 31.75M | 11.35M | 4.90M | 19.00M | |||
| Receivables | 25.91M | 32.01M | 47.84M | 42.30M | 32.50M | |||
| Inventories | 8.59M | 8.72M | 7.08M | 4.50M | 7.10M | |||
| Other Current Assets | 6.05M | 5.96M | 5.33M | 6.40M | 18.30M | |||
| Total Current Assets | 136.58M | 147.66M | 156.19M | 134.30M | 140.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.22M | 5.09M | 8.65M | 12.50M | 15.80M | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | 46.26M | 51.13M | 60.87M | 70.60M | 66.10M | |||
| Other Non-Current Assets | 8.86M | 9.45M | 4.83M | 4.70M | 4.70M | |||
| Total Non-Current Assets | 58.34M | 65.67M | 74.34M | 87.80M | 86.60M | |||
| TOTAL ASSETS | 194.92M | 213.33M | 230.53M | 222.10M | 226.60M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | 34.00M | 45.33M | 34.00M | null | 0 | |||
| Accrued Expenses | 36.16M | 42.44M | 57.52M | 69.70M | 96.10M | |||
| Accounts Payable | 5.42M | 5.51M | 6.89M | 6.40M | 11.20M | |||
| Other Current Liabilities | 3.52M | 2.83M | 975.00K | 1.40M | 2.30M | |||
| Total Current Liabilities | 79.10M | 96.11M | 99.38M | 77.50M | 109.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 10.87M | 21.72M | 65.66M | 98.30M | 97.10M | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 230.00K | 3.38M | 12.04M | 24.70M | 22.40M | |||
| Total Non-Current Liabilities | 11.10M | 25.10M | 77.70M | 123.00M | 119.40M | |||
| TOTAL LIABILITIES | 90.20M | 121.21M | 177.09M | 200.50M | 229.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.31B | -1.31B | -1.35B | -1.37B | -1.37B | |||
| Additional Paid In Capital | 1.41B | 1.41B | 1.40B | 1.39B | 1.36B | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 5.00K | 5.00K | 5.00K | 0 | 0 | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | -14.00K | 6.00K | -4.00K | 0 | 0 | |||
| Shares Outstanding | 49.89M | 49.11M | 47.65M | 46.30M | 41.20M | |||
| Tangible Book Value per Share | 1.1716 | 0.8348 | -0.1559 | -1.0583 | -1.6626 | |||
| Total Shareholders' Equity | 104.72M | 92.13M | 53.44M | 21.60M | -2.40M | |||
| TOTAL LIABILITIES AND EQUITY | 194.92M | 213.33M | 230.53M | 222.10M | 226.60M | |||
| Statistics | ||||||||
| Debt/Equity | 0.10 | 0.24 | 1.23 | 4.55 | -40.46 | |||
| Current Ratio | 1.73 | 1.54 | 1.57 | 1.73 | 1.28 | |||
| Return On Assets (ROA) | 24.86% | 14.19% | 9.37% | N/A | -12.84% | |||
| Return On Equity (ROE) | 46.27% | 32.87% | 40.40% | N/A | N/A | |||
| Return On Invested Capital (ROIC) | 31.42% | 20.87% | 20.04% | 13.00% | 0.88% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 183.86% | 150.48% | 74.64% | 29.61% | 2.94% | |||
All data in USD , ROIC based on taxRate of 0.21